KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,842,063 | -64.6% | 22,722 | -54.6% | 0.04% | -65.1% |
| Q2 2023 | $10,864,185 | +231.1% | 50,100 | +243.5% | 0.13% | +180.4% |
| Q3 2022 | $3,281,000 | -82.3% | 14,585 | -90.1% | 0.05% | -83.9% |
| Q2 2022 | $18,563,000 | +70.3% | 146,735 | +70.6% | 0.29% | +61.6% |
| Q1 2022 | $10,903,000 | +396.5% | 85,990 | +412.9% | 0.18% | +471.0% |
| Q4 2021 | $2,196,000 | +68.3% | 16,764 | +57.1% | 0.03% | +47.6% |
| Q3 2021 | $1,305,000 | +7.3% | 10,668 | 0.0% | 0.02% | -8.7% |
| Q2 2021 | $1,216,000 | -5.2% | 10,668 | 0.0% | 0.02% | -17.9% |
| Q1 2021 | $1,283,000 | – | 10,668 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |